Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (61-70 of 721) with videos related to

Pageof 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Current Concepts in <sup>68</sup>Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular StrategiesLisa Bodei, Valentina Ambrosini, Ken Herrmann, et al.
Seminars in Nuclear Medicine|October 22, 2019
PET/MR Imaging of the Female PelvisLale Umutlu, Gerald Antoch, Ken Herrmann, et al.
Seminars in Nuclear Medicine|August 14, 2021
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?Lutz S Freudenberg, Kelsey L Pomykala, Ken Herrmann
European Urology|October 13, 2023
A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?Ulrich Krafft, Boris A Hadaschik, Katharina Lückerath, et al.
Current Radiology Reports|June 3, 2014
PET/CT in Oncology: Current Status and PerspectivesJohannes Czernin, Martin Allen-Auerbach, David Nathanson, et al.
Current Opinion in Urology|August 1, 2020
Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrenceJustin Ferdinandus, Wolfgang Peter Fendler, Boris Hadaschik, et al.
European Urology|August 3, 2016
<sup>68</sup>Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging: The New Kid on the Block-Early or Too Early to Draw Conclusions?Matthias Eiber, Ken Herrmann, Wolfgang P Fendler, et al.
Seminars in Nuclear Medicine|December 14, 2025
Treatment response assessment according to updated PROMISE criteriaTugce Telli, Caner Civan, Ken Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Targeted Radiation, Unintended EvolutionKatharina Lueckerath, Boris Hadaschik, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2016
Variations in PET/MRI Operations: Results from an International Survey Among 39 Active SitesWolfgang Peter Fendler, Johannes Czernin, Ken Herrmann, et al.
Pageof 73

Showing results (61-70 of 721) with videos related to

Sort By:
Pageof 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Current Concepts in <sup>68</sup>Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular StrategiesLisa Bodei, Valentina Ambrosini, Ken Herrmann, et al.
Seminars in Nuclear Medicine|October 22, 2019
PET/MR Imaging of the Female PelvisLale Umutlu, Gerald Antoch, Ken Herrmann, et al.
Seminars in Nuclear Medicine|August 14, 2021
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?Lutz S Freudenberg, Kelsey L Pomykala, Ken Herrmann
European Urology|October 13, 2023
A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?Ulrich Krafft, Boris A Hadaschik, Katharina Lückerath, et al.
Current Radiology Reports|June 3, 2014
PET/CT in Oncology: Current Status and PerspectivesJohannes Czernin, Martin Allen-Auerbach, David Nathanson, et al.
Current Opinion in Urology|August 1, 2020
Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrenceJustin Ferdinandus, Wolfgang Peter Fendler, Boris Hadaschik, et al.
European Urology|August 3, 2016
<sup>68</sup>Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging: The New Kid on the Block-Early or Too Early to Draw Conclusions?Matthias Eiber, Ken Herrmann, Wolfgang P Fendler, et al.
Seminars in Nuclear Medicine|December 14, 2025
Treatment response assessment according to updated PROMISE criteriaTugce Telli, Caner Civan, Ken Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Targeted Radiation, Unintended EvolutionKatharina Lueckerath, Boris Hadaschik, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2016
Variations in PET/MRI Operations: Results from an International Survey Among 39 Active SitesWolfgang Peter Fendler, Johannes Czernin, Ken Herrmann, et al.
Pageof 73